{"id":51413,"date":"2022-11-30T19:02:29","date_gmt":"2022-11-30T18:02:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/"},"modified":"2022-11-30T19:02:29","modified_gmt":"2022-11-30T18:02:29","slug":"medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/","title":{"rendered":"MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada"},"content":{"rendered":"
\n

YORBA LINDA, Calif.–(BUSINESS WIRE)–#AGM100<\/a>–Orange County, California based MediPines<\/a>, a global market leader in the development of gas exchange measurements, has announced that its MediPines AGM100<\/a>, the world\u2019s first FDA-cleared, non-invasive pulmonary gas exchange analyzer, is now available throughout Canada, thanks to an agreement with LevoMed Canada Inc.<\/a>, a company focused on providing the Canadian health care market with high quality innovative products.\n<\/p>\n

\nThis Canadian national distribution launch kicked off at the 50th<\/sup> meeting of the Respiratory Therapy Society of Ontario to help meet the growing demand for non-invasive assessments in the face of surging respiratory care.\n<\/p>\n

\nThe MediPines AGM100 is the world\u2019s only medical device which delivers a measure of a patient\u2019s Oxygen Deficit (a non-invasive respiratory impairment severity measurement). The technology provides reliable, discriminative readings that enable real-time decision support for healthcare providers during times of surging respiratory patients and medical staff shortages.\n<\/p>\n

\n\u201cAs the exclusive Canadian distribution partner of MediPines, we are excited to bring the benefits of the AGM100 to the Canadian healthcare system,\u201d said Madhu Venkat, LevoMed Canada\u2019s CEO. \u201cWe\u2019re enthusiastic about the partnership and are keen to support the growing need for effective, quick, and accurate gas exchange monitoring for the Canadian population with the help of the unique AGM100. It is an innovative cardiopulmonary diagnostic support technology, which we see as an important scientific innovation for detecting respiratory impairment non-invasively.\u201d\n<\/p>\n

\n\u201cIt\u2019s great to have a group of MedTech veterans such as Madhu, John, Mark, Perry, and William of the LevoMed team spearheading our technology adoption in leading hospitals throughout Canada, especially during this time of increased need,\u201d said MediPines CEO, Steve Lee.\n<\/p>\n

\nLast year, the World Health Organization (WHO) designated the MediPines AGM100 as one of notable innovative health technologies for the treatment of COVID-19 and other global priority diseases in its WHO Compendium of Innovative Health Technologies<\/a>.\n<\/p>\n

\nAbout MediPines<\/b>\n<\/p>\n

\nMediPines is a market leader in non-invasive pulmonary gas exchange technology. The company\u2019s mission is to advance respiratory medicine by providing physiology-based cardiorespiratory devices that enhance clinical effectiveness and achieve superior patient outcomes. The MediPines AGM100 is an FDA-cleared, advanced pulmonary gas exchange technology that exclusively provides Oxygen Deficit, a surrogate for the alveolar to arterial oxygen difference (AaDO2), as well as blood oxygen level (gPaO2<\/sub>), PETCO2<\/sub>, and other sensitive measurements of pulmonary gas exchange. Learn more at medipines.com<\/a>.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPaul Williams, 310-569-0023, paul@medialinecommunications.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

YORBA LINDA, Calif.–(BUSINESS WIRE)–#AGM100–Orange County, California based MediPines, a global market leader in the development of gas exchange measurements, has announced that its MediPines AGM100, the world\u2019s first FDA-cleared, non-invasive pulmonary gas exchange analyzer, is now available throughout Canada, thanks to an agreement with LevoMed Canada Inc., a company focused on providing the Canadian health … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51413","6":"format-standard","7":"category-industry"},"yoast_head":"\nMediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"YORBA LINDA, Calif.–(BUSINESS WIRE)–#AGM100–Orange County, California based MediPines, a global market leader in the development of gas exchange measurements, has announced that its MediPines AGM100, the world\u2019s first FDA-cleared, non-invasive pulmonary gas exchange analyzer, is now available throughout Canada, thanks to an agreement with LevoMed Canada Inc., a company focused on providing the Canadian health ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-30T18:02:29+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada\",\"datePublished\":\"2022-11-30T18:02:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\\\/\"},\"wordCount\":417,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\\\/\",\"name\":\"MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-11-30T18:02:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/","og_locale":"en_US","og_type":"article","og_title":"MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada - Pharma Trend","og_description":"YORBA LINDA, Calif.–(BUSINESS WIRE)–#AGM100–Orange County, California based MediPines, a global market leader in the development of gas exchange measurements, has announced that its MediPines AGM100, the world\u2019s first FDA-cleared, non-invasive pulmonary gas exchange analyzer, is now available throughout Canada, thanks to an agreement with LevoMed Canada Inc., a company focused on providing the Canadian health ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-30T18:02:29+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada","datePublished":"2022-11-30T18:02:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/"},"wordCount":417,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/","url":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/","name":"MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-11-30T18:02:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/medipines-expands-distribution-of-agm100-pulmonary-gas-exchange-technology-to-canada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51413"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51413\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}